A landmark study is a piece of research that fundamentally changed how scientists or doctors understand a topic, often becoming the foundation that hundreds or thousands of later studies build on. These studies don’t earn that label when they’re first published. It’s a status granted over time, as the wider scientific community recognizes that the work shifted an entire field’s direction.
What Makes a Study “Landmark”
There’s no official checklist or certification process. A study becomes landmark because it did something no previous research had done: identified a new disease mechanism, proved a treatment works, overturned a widely held assumption, or established a risk factor that nobody had connected before. Often, these are the first studies to make a specific discovery or draw a critical link between cause and effect.
The clearest indicator is citation frequency. When researchers across a field consistently reference the same study in their own work, that study has likely reached landmark status. If you look at the bibliography of five or six papers on the same topic and one study appears in all of them, you’ve probably found one. Landmark studies are typically cited by hundreds of other articles, sometimes thousands. They also tend to be published in top-tier journals, which reflects both the rigor of the work and the significance of the findings.
Importantly, no one knows at the time of publication whether a study will become landmark. It’s a retrospective label. You can’t search a database for “landmark studies” the way you’d filter by date or study type. Recognition comes only after the research has been tested, replicated, and absorbed into the broader body of knowledge.
How Long It Takes to Earn the Label
Scientific recognition moves slowly. After a study is published, it takes months for other researchers to read, evaluate, and cite it. Books and government reports incorporating the findings may not appear for a year or more. Specialized textbooks and encyclopedias that treat a study as established knowledge can take several years. So a study might be published today but not widely recognized as landmark for five, ten, or even twenty years, once its influence on practice and policy becomes undeniable.
Some studies gain traction faster than others, especially when they address urgent clinical questions or produce dramatic results. But even then, the scientific community needs time to replicate findings and observe real-world outcomes before consensus forms.
The Framingham Heart Study
Perhaps the most famous landmark study in modern medicine is the Framingham Heart Study, which has been called the most influential investigation in the history of cardiovascular research. Launched in 1948 in Framingham, Massachusetts, it followed thousands of residents over decades to understand what causes heart disease.
Before Framingham, doctors had limited understanding of why some people developed heart attacks and others didn’t. The study systematically identified the major risk factors we now take for granted: high blood pressure, high cholesterol, smoking, obesity, diabetes, and physical inactivity. These findings didn’t come all at once. In 1960, the study linked cigarette smoking to increased heart disease risk. In 1961, it connected cholesterol levels and blood pressure to heart disease. By 1967, physical activity was shown to be protective, and obesity was confirmed as a risk factor. In 1970, it established that high blood pressure increases stroke risk and that a common heart rhythm problem called atrial fibrillation raises stroke risk fivefold.
Framingham also introduced the concept of preventive cardiology, the idea that doctors should actively work to reduce risk factors before disease develops rather than just treating it afterward. The Framingham risk score, a tool still used today to estimate a person’s chance of developing heart disease, came directly from this research.
The Women’s Health Initiative
Another study that reshaped medical practice worldwide was the Women’s Health Initiative, a massive research program led by the National Institutes of Health. For decades, doctors routinely prescribed hormone replacement therapy to women after menopause, believing it protected against heart disease. The WHI proved that assumption wrong.
The study found that taking estrogen plus progestin after menopause actually raised the risk of heart disease, stroke, blood clots, breast cancer, and dementia. Estrogen alone (for women who had previously had a hysterectomy) showed some benefits for younger women but still increased the risk of stroke and blood clots. These findings led to a complete reversal in clinical guidelines: hormone therapy is no longer recommended to prevent heart disease or lower cholesterol in postmenopausal women, though it remains an option for some women early in menopause who have severe symptoms.
The WHI is a textbook example of a landmark study because it didn’t just add new knowledge. It overturned a common practice that millions of women were following on their doctors’ advice.
Landmark Studies in Cancer Treatment
Oncology provides several recent examples of studies that earned landmark status by dramatically improving survival for specific cancers. The CLEOPATRA trial tested a combination of targeted therapies for advanced breast cancer and found that adding a second targeted drug extended median survival by nearly 16 months compared to standard treatment, reaching 56.5 months overall. That’s the kind of result that immediately changes how oncologists treat patients.
The PALOMA 3 trial tested a newer class of drug for hormone-driven breast cancer that had spread. Patients receiving the new combination went roughly 9.5 months before their cancer progressed, compared to 4.6 months on standard therapy alone. In ovarian cancer, trials of a class of drugs called PARP inhibitors showed that women with certain genetic mutations could go 21 months without their cancer worsening, compared to 5.5 months on placebo. These are the kinds of clear, large differences that reshape treatment guidelines and earn a study its landmark reputation.
What Landmark Studies Have in Common
Despite spanning different fields and decades, landmark studies share several features. They typically use rigorous designs, most commonly randomized controlled trials, where participants are randomly assigned to receive either the treatment being tested or a comparison. This design minimizes bias and produces the most trustworthy evidence. They also tend to involve large numbers of participants followed over meaningful periods of time, which makes their results more generalizable and harder to dismiss.
Transparent reporting matters too. The scientific community has developed formal standards for how trials should be reported, covering everything from how participants were selected to how data was analyzed, whether funding sources had any influence on the results, and where the raw data can be accessed. Studies that meet these transparency standards are more likely to be trusted, replicated, and ultimately recognized as foundational.
That said, the definition is broadening. Traditionally, landmark studies were almost always randomized controlled trials. Increasingly, large-scale observational studies using real-world patient data are contributing important evidence, particularly for identifying rare side effects or long-term outcomes that controlled trials are too short or too small to capture. These real-world evidence studies analyze larger patient populations across longer timelines, and some are beginning to earn recognition alongside traditional trials.
How to Find Landmark Studies on a Topic
If you’re researching a health topic and want to identify the landmark studies behind current medical practice, the most reliable method is to read several recent review articles or clinical guidelines on that topic and look at which older studies appear repeatedly in their reference lists. A study cited by nearly every paper in a field is almost certainly a landmark.
You can also use citation-tracking tools like Web of Science or Google Scholar to see how many times a particular paper has been cited. A study with hundreds or thousands of citations in its field is a strong candidate. Keep in mind that citation counts vary by field: a highly cited study in a niche specialty might have 500 citations, while a highly cited study in cardiology or oncology might have 10,000 or more.